The results showed that SFAS-H could increase LVEF and LVFS, improve hypertrophy and necrosis of cardiomyocytes and myocardial fibrosis, and reduce cardiac ANP, BNP, NE, and MDA levels in CHF rats. The gene discussed is NPPB; the disease is Myocardial fibrosis.